Literature DB >> 22622159

Partial hepatectomy improves the outcome of intraportal islet transplantation by promoting revascularization.

Yukihiko Saito1, Nathaniel K Chan, Eba Hathout.   

Abstract

Revascularization of grafts is one of the important key factors for the success of islet transplantation. After partial hepatectomy, many growth factors such as hepatocyte growth factor and vascular endothelial growth factor are increased in the remnant liver. These growth factors have properties that promote angiogenesis. This might be an optimal environment for revascularization of islets transplanted intraportally. To verify this hypothesis, syngeneic islets (330 per recipient) were transplanted into the right hepatic lobes of streptozotocin-induced diabetic Balb/c mice with (hepatectomy group) or without (control group) left liver resection. Blood glucose was monitored for 28 d after transplantation. Glucose tolerance test was performed on post-operative day (POD) 30, and histological assessments were performed on POD 7 and 30 respectively. Analysis revealed that 36.7% of the control and 90.0% of the hepatectomy mice attained normoglycemia during the observation period (*p = 0.0142). Glucose tolerance was improved in the hepatectomy group (Area under the curve of intraperitoneal glucose tolerance tests on POD 30, Control; 47,700 ± 5,890 min*mg/dl, Hepatectomy; 26,000 ± 2,060 min*mg/dl: **p = 0.00314). Revascularization of grafted islets was more pronounced in the hepatectomy group (Vessel number per islet area on POD 7, Control; 3.20 ± 0.463 × 10 (-4) /µm ( 2) , Hepatectomy; 7.08 ± 0.513 × 10 (-4) /µm ( 2) : **p < 0.01). In the present study, partial hepatectomy (30%) improved the outcome of intraportal islet transplantation. Revascularization of islets transplanted into the liver may have been promoted by the induction of liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622159      PMCID: PMC3396702          DOI: 10.4161/isl.19491

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  28 in total

1.  Hepatic regeneration promotes engraftment of intraportally transplanted islet cells.

Authors:  Takeshi Sudo; Eiso Hiyama; Yoshiaki Murakami; Yujiro Yokoyama; Yoshio Takesue; Taijiro Sueda
Journal:  Surgery       Date:  2005-06       Impact factor: 3.982

Review 2.  Controversies in the use of portal vein embolization.

Authors:  Thomas M van Gulik; Jacomina W van den Esschert; Wilmar de Graaf; Krijn P van Lienden; Olivier R C Busch; Michal Heger; Otto M van Delden; Johan S Laméris; Dirk J Gouma
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

3.  Growth of intraportally transplanted islets under liver regeneration stimulus and restoration of normoglycemia in streptozocin-diabetic rats.

Authors:  E Morsiani; L Fogli; J Rozga; D Ricci; G Azzena; A A Demetriou
Journal:  Surgery       Date:  1998-04       Impact factor: 3.982

4.  DNA replication in mouse pancreatic islets transplanted subcapsularly into the kidney or intraportally into the liver. Influence of unilateral nephrectomy or partial hepatectomy.

Authors:  A Dunger; O Korsgren; A Andersson
Journal:  Transplantation       Date:  1990-04       Impact factor: 4.939

5.  Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets.

Authors:  G Miao; R P Ostrowski; J Mace; J Hough; A Hopper; R Peverini; R Chinnock; J Zhang; E Hathout
Journal:  Am J Transplant       Date:  2006-11       Impact factor: 8.086

Review 6.  Role of imaging in clinical islet transplantation.

Authors:  Gavin Low; Nassrein Hussein; Richard J T Owen; Christian Toso; Vimal H Patel; Ravi Bhargava; A M James Shapiro
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

7.  Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts.

Authors:  M Nakano; Y Yasunami; T Maki; S Kodama; Y Ikehara; T Nakamura; M Tanaka; S Ikeda
Journal:  Transplantation       Date:  2000-01-27       Impact factor: 4.939

Review 8.  Risks and side effects of islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; A M James Shapiro
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

9.  Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.

Authors:  Nan Zhang; Anja Richter; Jenny Suriawinata; Sonal Harbaran; Jennifer Altomonte; Lin Cong; Haojiang Zhang; Keying Song; Marcia Meseck; Jonathan Bromberg; Hengjiang Dong
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

10.  β-Cell Generation: Can Rodent Studies Be Translated to Humans?

Authors:  Françoise Carlotti; Arnaud Zaldumbide; Johanne H Ellenbroek; H Siebe Spijker; Rob C Hoeben; Eelco J de Koning
Journal:  J Transplant       Date:  2011-10-05
View more
  3 in total

1.  Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetes.

Authors:  Salamah M Alwahsh; Omar Qutachi; Philip J Starkey Lewis; Andrew Bond; June Noble; Paul Burgoyne; Nik Morton; Rod Carter; Janet Mann; Sofia Ferreira-Gonzalez; Marta Alvarez-Paino; Stuart J Forbes; Kevin M Shakesheff; Shareen Forbes
Journal:  Am J Transplant       Date:  2021-02-02       Impact factor: 9.369

Review 2.  Revascularization of transplanted pancreatic islets and role of the transplantation site.

Authors:  Andrew R Pepper; Boris Gala-Lopez; Oliver Ziff; A M James Shapiro
Journal:  Clin Dev Immunol       Date:  2013-09-09

3.  Partial-Hepatectomized (70%) Model Shows a Correlation between Hepatocyte Growth Factor Levels and Beta-Cell Mass.

Authors:  Tiago G Araújo; Alexandre G Oliveira; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.